Cargando…

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

BACKGROUND: Multiple myeloma (MM) is an incurable haematological malignancy characterised by the clonal proliferation of malignant plasma cells within the bone marrow. We have previously identified pituitary tumour transforming gene 1 (Pttg1) as a gene that is significantly upregulated in the haemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Noll, Jacqueline E., Vandyke, Kate, Hewett, Duncan R., Mrozik, Krzysztof M., Bala, Rachel J., Williams, Sharon A., Kok, Chung H., Zannettino, Andrew CW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595141/
https://www.ncbi.nlm.nih.gov/pubmed/26445238
http://dx.doi.org/10.1186/s13045-015-0209-2
_version_ 1782393546730373120
author Noll, Jacqueline E.
Vandyke, Kate
Hewett, Duncan R.
Mrozik, Krzysztof M.
Bala, Rachel J.
Williams, Sharon A.
Kok, Chung H.
Zannettino, Andrew CW
author_facet Noll, Jacqueline E.
Vandyke, Kate
Hewett, Duncan R.
Mrozik, Krzysztof M.
Bala, Rachel J.
Williams, Sharon A.
Kok, Chung H.
Zannettino, Andrew CW
author_sort Noll, Jacqueline E.
collection PubMed
description BACKGROUND: Multiple myeloma (MM) is an incurable haematological malignancy characterised by the clonal proliferation of malignant plasma cells within the bone marrow. We have previously identified pituitary tumour transforming gene 1 (Pttg1) as a gene that is significantly upregulated in the haematopoietic compartment of the myeloma-susceptible C57BL/KaLwRij mouse strain, when compared with the myeloma-resistant C57BL/6 mouse. Over-expression of PTTG1 has previously been associated with malignant progression and an enhanced proliferative capacity in solid tumours. METHODS: In this study, we investigated PTTG1 gene and protein expression in MM plasma cells from newly diagnosed MM patients. Gene expression profiling was used to identify gene signatures associated with high PTTG1 expression in MM patients. Additionally, we investigated the effect of short hairpin ribonucleic acid (shRNA)-mediated PTTG1 knockdown on the proliferation of the murine myeloma plasma cell line 5TGM1 in vitro and in vivo. RESULTS: PTTG1 was found to be over-expressed in 36–70 % of MM patients, relative to normal controls, with high PTTG1 expression being associated with poor patient outcomes (hazard ratio 2.49; 95 % CI 1.28 to 4.86; p = 0.0075; log-rank test). In addition, patients with high PTTG1 expression exhibited increased expression of cell proliferation-associated genes including CCNB1, CCNB2, CDK1, AURKA, BIRC5 and DEPDC1. Knockdown of Pttg1 in 5TGM1 cells decreased cellular proliferation, without affecting cell cycle distribution or viability, and decreased expression of Ccnb1, Birc5 and Depdc1 in vitro. Notably, Pttg1 knockdown significantly reduced MM tumour development in vivo, with an 83.2 % reduction in tumour burden at 4 weeks (p < 0.0001, two-way ANOVA). CONCLUSIONS: This study supports a role for increased PTTG1 expression in augmenting tumour development in a subset of MM patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-015-0209-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4595141
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45951412015-10-07 PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma Noll, Jacqueline E. Vandyke, Kate Hewett, Duncan R. Mrozik, Krzysztof M. Bala, Rachel J. Williams, Sharon A. Kok, Chung H. Zannettino, Andrew CW J Hematol Oncol Research BACKGROUND: Multiple myeloma (MM) is an incurable haematological malignancy characterised by the clonal proliferation of malignant plasma cells within the bone marrow. We have previously identified pituitary tumour transforming gene 1 (Pttg1) as a gene that is significantly upregulated in the haematopoietic compartment of the myeloma-susceptible C57BL/KaLwRij mouse strain, when compared with the myeloma-resistant C57BL/6 mouse. Over-expression of PTTG1 has previously been associated with malignant progression and an enhanced proliferative capacity in solid tumours. METHODS: In this study, we investigated PTTG1 gene and protein expression in MM plasma cells from newly diagnosed MM patients. Gene expression profiling was used to identify gene signatures associated with high PTTG1 expression in MM patients. Additionally, we investigated the effect of short hairpin ribonucleic acid (shRNA)-mediated PTTG1 knockdown on the proliferation of the murine myeloma plasma cell line 5TGM1 in vitro and in vivo. RESULTS: PTTG1 was found to be over-expressed in 36–70 % of MM patients, relative to normal controls, with high PTTG1 expression being associated with poor patient outcomes (hazard ratio 2.49; 95 % CI 1.28 to 4.86; p = 0.0075; log-rank test). In addition, patients with high PTTG1 expression exhibited increased expression of cell proliferation-associated genes including CCNB1, CCNB2, CDK1, AURKA, BIRC5 and DEPDC1. Knockdown of Pttg1 in 5TGM1 cells decreased cellular proliferation, without affecting cell cycle distribution or viability, and decreased expression of Ccnb1, Birc5 and Depdc1 in vitro. Notably, Pttg1 knockdown significantly reduced MM tumour development in vivo, with an 83.2 % reduction in tumour burden at 4 weeks (p < 0.0001, two-way ANOVA). CONCLUSIONS: This study supports a role for increased PTTG1 expression in augmenting tumour development in a subset of MM patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-015-0209-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-06 /pmc/articles/PMC4595141/ /pubmed/26445238 http://dx.doi.org/10.1186/s13045-015-0209-2 Text en © Noll et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Noll, Jacqueline E.
Vandyke, Kate
Hewett, Duncan R.
Mrozik, Krzysztof M.
Bala, Rachel J.
Williams, Sharon A.
Kok, Chung H.
Zannettino, Andrew CW
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
title PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
title_full PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
title_fullStr PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
title_full_unstemmed PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
title_short PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
title_sort pttg1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595141/
https://www.ncbi.nlm.nih.gov/pubmed/26445238
http://dx.doi.org/10.1186/s13045-015-0209-2
work_keys_str_mv AT nolljacquelinee pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma
AT vandykekate pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma
AT hewettduncanr pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma
AT mrozikkrzysztofm pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma
AT balarachelj pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma
AT williamssharona pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma
AT kokchungh pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma
AT zannettinoandrewcw pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma